Sengul N, Wexner S D, Woodhouse S, Arrigain S, Xu M, Larach J A, Ahn B K, Weiss E G, Nogueras J J, Berho M
Department of Colorectal Surgery, Cleveland Clinical Florida, Weston, Florida 33331, USA.
Colorectal Dis. 2006 May;8(4):283-8. doi: 10.1111/j.1463-1318.2005.00934.x.
Down staging by pre-operative chemoradiotherapy is currently considered part of the standard therapeutic approach to rectal carcinoma. The aim of this study was to assess the response to chemoradiotherapy of different histopathological types of rectal carcinoma with emphasis on the mucinous variant.
Between 1997 and 2002, 71 patients who received pre-operative chemoradiotherapy followed by surgery for rectal carcinoma were enrolled in the study. Staging of the rectal carcinoma was performed according to transrectal ultrasound findings (TN score) prior to the chemoradiotherapy. The chemoradiotherapy was followed by radical resection with mesorectal excision. All surgical specimens were examined by a single pathologist (MB). Pathological TN staging was assessed and tumour regression was graded according to a standard method (TRG1, complete response - TRG5 no response). Tumours were classified as mucinous or nonmucinous according to pre- and post-operative biopsy and specimen histopathological types. TN score change and TRG differences between groups were assessed.
Tumour regression was seen after chemoradiotherapy in 94.4% of the patients, while in 5.6% of the patients no response was found. The change in TN score and TRG were correlated. Higher TRG was associated with a smaller decrease in TN staging. TRG was significantly lower in the nonmucinous compared to the mucinous group and the decrease in TN grade was significantly larger in the nonmucinous group.
Mucinous carcinoma was associated with a lower response to pre-operative chemo-radiotherapy in this group of rectal carcinoma patients. Further studies are needed to determine its prognostic value.
术前放化疗降期目前被认为是直肠癌标准治疗方法的一部分。本研究的目的是评估不同组织病理学类型的直肠癌对放化疗的反应,重点是黏液性变体。
1997年至2002年期间,71例接受术前放化疗后行直肠癌手术的患者纳入本研究。在放化疗前根据经直肠超声检查结果(TN评分)对直肠癌进行分期。放化疗后行根治性直肠系膜切除术。所有手术标本由一名病理学家(MB)检查。评估病理TN分期,并根据标准方法对肿瘤退缩进行分级(TRG1,完全缓解 - TRG5,无反应)。根据术前和术后活检及标本组织病理学类型将肿瘤分为黏液性或非黏液性。评估组间TN评分变化和TRG差异。
94.4%的患者在放化疗后出现肿瘤退缩,而5.6%的患者无反应。TN评分变化与TRG相关。TRG越高,TN分期降低越小。非黏液性组的TRG显著低于黏液性组,非黏液性组的TN分级降低显著更大。
在这组直肠癌患者中,黏液腺癌对术前放化疗的反应较低。需要进一步研究以确定其预后价值。